Animal vaccine
Poultry Vaccine
In the poultry breeding industry, epidemic prevention and control is the first line of defense to ensure breeding benefits and safeguard food safety. Our poultry vaccine series, developed based on the physiological characteristics and epidemic prevalence rules of poultry such as chickens, ducks, and geese at different growth stages, provides a full-cycle and multi-dimensional epidemic prevention solution, covering core diseases including highly pathogenic avian influenza, Newcastle disease, infectious bronchitis, duck plague, and gosling plague.
Combined with the actual needs of large-scale breeding, we offer various formulations such as freeze-dried vaccines, inactivated vaccines, and combined vaccines, adapting to different vaccination methods including drinking water, nasal drops, eye drops, and injection. These not only meet the high-efficiency epidemic prevention requirements of intensive breeding but also accommodate the flexible operation of small and medium-sized farms. During the R&D process, we continuously track the variation trends of epidemic strains in various regions and regularly update vaccine strains to ensure that the immune effect is highly matched with the prevalent strains and effectively block the epidemic transmission chain.
Ruminant Animal Vaccine
Ruminants such as cattle and sheep are the core industrial carriers of the herbivorous livestock industry. Their health status is directly related to the economic development of the livestock industry and the supply security of products such as meat, milk, and wool. Our ruminant vaccine series focuses on major epidemic threats in ruminant breeding, including foot-and-mouth disease, bovine viral diarrhea-mucosal disease, peste des petits ruminants, sheep pox, and brucellosis, providing "comprehensive and strong protection" immune support for ruminant breeding.
Considering the coexistence of large-scale and free-range ruminant breeding, special attention is paid to applicability and stability in vaccine R&D: freeze-dried vaccines can maintain activity for a long time under conventional refrigeration conditions, while inactivated vaccines have excellent immune durability, providing effective protection for animals for 6-12 months with a single vaccination. For zoonoses such as brucellosis, our vaccines can not only reduce the animal infection rate but also minimize the risk of epidemic transmission to humans from the source, safeguarding the health of breeding personnel and public health security.
Porcine Vaccine
The swine industry is a pillar of the livestock sector, closely related to people's livelihood supply and agricultural economic stability. With the goal of "Prevention First, Capacity Guarantee", our swine vaccine series is developed to address epidemic risks across the entire swine industry chain, offering high-quality vaccines covering major diseases such as classical swine fever, foot-and-mouth disease, highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS), porcine circovirus type 2 (PCV2) infection, and pseudorabies.
Facing the current situation of complex and volatile swine epidemics and frequent co-infections of multiple pathogens, we have launched multi-combination and multi-valent vaccines. These can prevent multiple diseases simultaneously, reduce vaccination frequency and stress responses, lowering breeding costs while improving epidemic prevention efficiency. Adopting advanced cell culture technology and purification processes in production, our vaccines ensure high purity and low impurities. They can induce rapid antibody production after immunization, shorten the immune gap period, and provide precise protection for different swine groups including piglets, finishers, and breeding pigs.
Pet Vaccine
Every pet is an indispensable member of the family. Their health and happiness touch the heartstrings of every owner. Guided by the core R&D philosophy of "Precise Protection, Gentle Care", our pet vaccine series covers major virulent infectious diseases susceptible to common companion animals such as dogs and cats, including rabies, canine distemper, feline panleukopenia, and canine parvovirus disease.
Adopting internationally advanced genetic engineering technology and purification processes, we ensure high immunogenicity of the vaccines while minimizing the risk of adverse reactions. Even young pets or elderly pets with sensitive constitutions can receive safe and reliable protection. Throughout the entire process from vaccine production to cold chain transportation, we strictly adhere to GMP standards and quality control systems. Each vaccine is attached with a unique traceable identifier, allowing owners to clearly understand the vaccine's source and batch information, truly achieving "Assured Vaccination, Peace of Mind Protection.